FindTrial
Sign In

Clinical-Pathological Features and Prognosis of the Patient with Papillary Thyroid Carcinoma and Severe Aplastic Anemia Simultaneously

Clinical-Pathological Features and Prognosis of the Patient with Papillary Thyroid Carcinoma and Severe Aplastic Anemia Simultaneously

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064996
Enrollment
Unknown
Registered
2022-10-25
Start date
2022-08-04
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Papillary Thyroid Carcinoma, Severe Aplastic Anemia

Interventions

None listed

Sponsors

Guangzhou First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 48 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with papillary thyroid cancer and severe aplastic anemia simultaneously.

Exclusion criteria

Exclusion criteria: 1. Patients did not receive any treatments; 2. Adverse events impact the treatments, such as thyroidectomy, radioiodine ablation, immunosuppressive therapy, and hematopoietic stem cell transplantation.

Design outcomes

Primary

MeasureTime frame
Survival;Recurrence;Cliniacal-Pathological Features;—

Countries

China

Contacts

Public ContactJianhua Feng

Guangzhou First People's Hospital

fengjianhua08@163.com+86 13533974828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026